Man Group
ARCT icon

Man Group’s Arcturus Therapeutics ARCT Stock Holding History

Man Group’s Portfolio ARCT Stock Details ARCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-13,264
Closed -$173K – 2203
2025
Q2 		$173K Sell
13,264
-3,231
-20% -$38.2K ﹤0.01% 2090
2025
Q1 		$175K Sell
16,495
-5,473
-25% -$86.9K ﹤0.01% 2050
2024
Q4 		$373K Sell
21,968
-4,168
-16% -$78.5K ﹤0.01% 1735
2024
Q3 		$607K Buy
26,136
+9,346
+56% +$200K ﹤0.01% 1619
2024
Q2 		$409K Sell
16,790
-45,799
-73% -$1.39M ﹤0.01% 1730
2024
Q1 		$2.11M Sell
62,589
-23,914
-28% -$847K 0.01% 1295
2023
Q4 		$2.73M Buy
+86,503
New +$2.06M 0.01% 1175
2023
Q3 		– Hold
0
– – – 1267
2022
Q1 		– Sell
-17,390
Closed -$644K – 2175
2021
Q4 		$644K Sell
17,390
-2,569
-13% -$105K ﹤0.01% 1464
2021
Q3 		$954K Buy
19,959
+2,694
+16% +$121K ﹤0.01% 1349
2021
Q2 		$584K Sell
17,265
-1,811
-9% -$61.3K ﹤0.01% 1516
2021
Q1 		$788K Buy
19,076
+7,338
+63% +$437K ﹤0.01% 1353
2020
Q4 		$509K Sell
11,738
-186
-2% -$12.6K ﹤0.01% 1548
2020
Q3 		$512K Buy
+11,924
New +$592K ﹤0.01% 1544

Other funds holding ARCT

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SSA
Schonfeld Strategic Advisors New York $27.9B AUM 51.18% 1-Year Est. Return

Man Group's ARCT Position: Q3 2025 in Review

Man Group sold out of Arcturus Therapeutics (ARCT) in Q3 2025, closing a stake of 13,264 shares — an estimated $173K sold.

Man Group first reported a position in ARCT in Q3 2020 and held it in 13 quarters. The position peaked at $2.73M in Q4 2023. 136 funds tracked by Wall St. Rank hold ARCT as of Q3 2025.

  • Man Group reported no remaining Arcturus Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Man Group sold 13,264 Arcturus Therapeutics shares in Q3 2025, an estimated $173K.
  • Man Group first reported a position in Arcturus Therapeutics in Q3 2020 and held it in 13 quarters.
  • Man Group's Arcturus Therapeutics position peaked at $2.73M in Q4 2023.
  • 136 funds tracked by Wall St. Rank held Arcturus Therapeutics as of Q3 2025.

Based on Man Group's 13F filing for Q3 2025, filed 14 Nov 2025.